L. Chang - Apr 1, 2022 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Role: Chief Medical Officer
Signature: /s/ Michael L. Chang
Stock symbol: NUTX
Transactions as of: Apr 1, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/5/2022, 03:46 PM
Next filing: Jun 28, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUTX	Common Stock	Award		+12M			12M	Apr 1, 2022	By Michael Chang PLLC	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	At the closing of the business combination pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 14, 2022, as supplemented, the reporting person received 3.571428575 shares of Common Stock of the Issuer in exchange for each membership interest in Nutex Health Holdco LLC.

Content

At the closing of the business combination pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 14, 2022, as supplemented, the reporting person received 3.571428575 shares of Common Stock of the Issuer in exchange for each membership interest in Nutex Health Holdco LLC.